Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • Health Equity through Her Lens
    • The Health Equity podcast
    • Access insights
    • Health Equity through Her Lens
    • The Health Equity podcast
  • News
  • Our team
  • Featured insights
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

Date

24 April 2020

Covid-19: Corrida por vacina se acirra com testes em humanos na Alemanha

This piece by Amanda Péchy for the Brazilian magazine Veja looks at efforts being made by pharmaceutical companies around the globe to create and test a vaccine for COVID-19.

Direct links

Read the full article

The article delves into efforts being made by pharmaceutical companies around the world, including in Germany, China, the UK, the United States, and Norway in creating and testing vaccine candidates for COVID-19. The article reports that while some companies have already begun testing vaccine candidates, others are still conducting preliminary research. 

The article also looks at the potential barriers expected in the creation and distribution of a vaccine, noting that thorough testing is crucial in developing an option that is safe, effective, and accessible. The article quotes Danny Edwards, Research Programme Manager for the Access to Medicine Index, regarding issues of accessibility surrounding an eventual vaccine: 

"Nobody should be left behind. This has a moral aspect, but it also has a practical aspect: for a pandemic vaccine to be effective, it needs to be available globally."

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved